“I’ll move to the Azores if you want,” I said to my wife, Samantha, after a conflict with an extended family member, who ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity ...

New Zealand today approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called “magic ...

Dr Cameron Lacey, the first psychiatrist granted approval to prescribe the Class A drug psilocybin, said it took energy and ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

SANTA FE — New Mexico this week becomes the third state to launch a state-run medical psilocybin program, but don't expect magic mushrooms to be widely offered any time soon. State officials have ...

A new trial is testing whether psilocybin, the active ingredient in magic mushrooms, can provide relief from depression in ...